GBT Pharma has helped build international market success for a range of leading healthcare companies. Here are just some of our partners, past and present.
GBT Pharma has helped to build and manage international markets as consultancy partner to this Swiss pharmaceutical company.
Creso Pharma is working to develop and produce safe, cannabis- and hemp- derived therapeutic products and treatments for humans and pets. GBT Pharma founder Gian Trepp was appointed as a Commercial Industry advisor to Creso Pharma in April 2017.
GBT Pharma has provided a range of services to Executive Insight, a healthcare consultants firm. This has included global brand management and advising on the roll out of healthcare products on an international scale.
Herbonis is a Swiss life sciences company who provide natural vitamin D metabolites (1,25-Dihydroxyvitamin D3-glycosides) from botanical sources. GBT Pharma is working with Herbonis to support their work in furthering scientific knowledge of the role of botanically sourced active vitamin D extracts in supporting bone health.
Iscador is an anthroposophic mistletoe preparation and prescription only drug used for the adjuvant treatment of tumorous diseases in the field of integrative oncology. GBT Pharma is working to increase Iscador’s international market presence.
GBT Pharma has provided strategic consultancy services to this leading Austrian OTC company regarding their OTC products.
As partner to this Swiss pharmaceutical company, GBT Pharma is currently working with Parsenn-Produkte to help build their international presence.
GBT Pharma has been working with this leading Swiss Homeopathic company since 2011 to aid their international growth.
Vifor Pharma is a world market leader in anaemia treatments. In his senior roles at Vifor Pharma, Gian oversaw a range of global brand management and product development projects.